In today’s digital laboratory environment, seamless integration between lab instruments and enterprise systems is no longer a luxury, it is a necessity. Scientific teams demand real-time access to data, IT departments require robust cybersecurity, and Quality Assurance expects traceability at every step. The challenge? Finding a secure and scalable way to connect lab instruments to your LIMS or ELN without exposing your lab to external threats. 

LabWare proudly announces that Hunter Nelson, Certified LIMS Implementation Consultant with LabWare Global Services, was selected to participate in the 2025 Water Leadership Institute (WLI), a prestigious program hosted by the Water Environment Federation (WEF). Meet the WLI class of 2025 → 

The Arizona sun, the historic backdrop of Old Tucson, and hundreds from the LabWare community came together this April for an unforgettable week of insight, innovation, and connection at the 2025 LabWare North American Customer Education Conference. 

From first-time attendees to customers with over 25 years of LabWare experience, this year’s CEC brought together a vibrant cross-section of users across industries. It offered a unique opportunity to collaborate, learn, and explore new ways to maximize LabWare systems, delivering both meaningful value and memorable moments. 

In today's fast-paced laboratory environment, efficiency, accuracy, and compliance are more critical than ever. However, many labs continue to operate without a modern Laboratory Information Management System (LIMS) due to perceived costs, fear of disruption, or reliance on outdated legacy systems. 

Laboratories that delay upgrading their systems face operational inefficiencies and compliance risks, making it harder for them to compete with those that have embraced digital transformation. 

If your lab is hesitant to adopt a LIMS, it's crucial to grasp the full extent of what that decision could cost you. Here's a look at what's at stake. 

LabWare Japan is shaping the future of laboratory automation while fostering a dynamic and flexible work environment. In a recent interview with Mirai’s Work, Yohei Eto (Japan Territory Manager) and Masahiro Maeda (Sales Executive) shared insights into the company’s culture, global collaboration, and career opportunities.

Now that 2025 is underway, it’s an ideal time to reflect on the insights, innovations, and milestones captured in our 2024 LIMS World blog posts. These articles delivered actionable strategies and cutting-edge developments for laboratory leaders and informatics professionals to streamline operations, ensure compliance, and leverage emerging technologies. Here’s a concise year-end review of the blog topics that resonated most with our audience and why they matter for your lab’s future.

As labs adapt to a dynamic and increasingly data-driven environment, the role of Laboratory Information Systems (LIS) is evolving rapidly. In Medical Laboratory Observer’s 2024 LIS Market Overview, Ed Krasovec from LabWare discusses the significant shifts impacting labs today, focusing on the integration of advanced analytics, automation, and staff support. Here, we’ll explore these trends, insights from Ed’s recent responses, and how LabWare’s Clinical Health Solution is primed to address them. 

ZURICH, SWITZERLAND

The biopharmaceutical industry demands exacting standards in quality assurance and quality control (QA/QC). Precision and consistency in laboratory operations are critical as companies navigate complex regulatory environments. A Laboratory Information Management System (LIMS) tailored for biopharmaceutical QA/QC significantly enhances operational efficiency, ensures regulatory compliance, and improves data integrity. 

LIMS supports biopharmaceutical labs by automating workflows, enhancing data accuracy, and enabling real-time decision-making.  

Efficient critical reagent lifecycle management in bioanalytical laboratories is vital to ensuring accurate and reproducible assay performance. Critical reagents are vital in various assays, particularly in neutralizing antibody (NAb) testing, where precision is non-negotiable. NAbs are a subset of anti-drug antibodies (ADAs) that play an essential role in understanding the efficacy and safety of a biological drug. While a traditional bioanalytical LIMS (Laboratory Information Management System) provides some support, it lacks comprehensive capabilities for detailed reagent management. A single configurable LIMS and ELN (Electronic Laboratory Notebook) platform offers a more complete bioanalytical solution, enhancing laboratory efficiency and compliance. 

In a recent letterdated June 17, 2024, the FDA raised significant concerns about the data integrity and management practices at a contract research organization (CRO), highlighting issues with their ISR processes during bioanalytical studies. This letter detailed several critical areas where data anomalies and mishandling led to questions about the reliability of bioanalytical study results. Here, we explore the FDA's ISR findings and discuss how LabWare's Bioanalytical LIMS and ELN platform could have mitigated these issues.